Avantor, Inc. (AVTR): Price and Financial Metrics

Avantor, Inc. (AVTR)

Today's Latest Price: $17.53 USD

0.54 (3.18%)

Updated Jul 2 7:00pm

Add AVTR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 33 in Consumer Goods

See all "A" rated Strong Buy stocks

AVTR Stock Summary

  • AVTR's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.31 -- higher than just 5.51% of US-listed equities with positive expected earnings growth.
  • AVTR's went public 1.13 years ago, making it older than merely 0.74% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of -25.59%, Avantor Inc's debt growth rate surpasses just 11.36% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Avantor Inc are AWI, PKG, VSLR, POST, and RILY.
  • Visit AVTR's SEC page to see the company's official filings. To visit the company's web site, go to www.avantorsciences.com.
AVTR Daily Price Range
AVTR 52-Week Price Range

AVTR Stock Price Chart Technical Analysis Charts

AVTR Price/Volume Stats

Current price $17.53 52-week high $19.50
Prev. close $16.99 52-week low $6.66
Day low $17.17 Volume 5,590,408
Day high $17.87 Avg. volume 3,641,355
50-day MA $17.23 Dividend yield N/A
200-day MA $16.04 Market Cap 10.08B

Avantor, Inc. (AVTR) Company Bio

Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.

AVTR Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

Below please find a table outlining a discounted cash flow forecast for AVTR, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Avantor Inc ranked in the 96th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Avantor Inc, consider:

  • The company's compound free cash flow growth rate over the past 0.99 years comes in at 1.98%; that's greater than 95.81% of US stocks we're applying DCF forecasting to.
  • As a business, Avantor Inc experienced a tax rate of about 2% over the past twelve months; relative to its sector (Basic Materials), this tax rate is higher than merely 20.25% of stocks generating free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

FUL, BTG, DOW, ITP, and FRTA can be thought of as valuation peers to AVTR, in the sense that they are in the Basic Materials sector and have a similar price forecast based on DCF valuation.

AVTR Latest News Stream

Event/TimeNews Detail
Loading, please wait...

AVTR Latest Social Stream

Loading social stream, please wait...

View Full AVTR Social Stream

Latest AVTR News From Around the Web

Below are the latest news stories about Avantor Inc that investors may wish to consider to help them evaluate AVTR as an investment opportunity.

Avantor® to Report Second Quarter Earnings and Host Earnings Call on Wednesday, July 29, 2020

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that it will release its financial results for the second quarter 2020 after the market closes on Wednesday, July 29, 2020, and will hold a conference call on the same day to discuss the results at 5:00 pm EDT.

Yahoo | July 1, 2020

Avantor® Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene Therapy

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced the expansion of the company's Bridgewater, N.J. (USA) innovation center. Located close to biotech companies, the site now has nearly double the laboratory and support space.

Yahoo | June 30, 2020

Avantor® Named to Fortune 500 List

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, today announced its first inclusion in the Fortune 500 list, ranking 484 on the list of the largest U.S. companies by revenue.

Yahoo | June 23, 2020

Do Hedge Funds Love Avantor, Inc. (AVTR)?

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

Yahoo | June 8, 2020

8 Stocks Viking Global Investors Continues to Buy

Visa and Cigna make the list Continue reading...

Yahoo | May 29, 2020

Read More 'AVTR' Stories Here

AVTR Price Returns

1-mo -5.14%
3-mo 43.92%
6-mo -5.19%
1-year -8.60%
3-year N/A
5-year N/A
YTD -3.42%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7616 seconds.